338 related articles for article (PubMed ID: 8887900)
1. Effects of growth hormone and insulin-like growth factor 1 (IGF-1) treatments on the nitrogen metabolism and hepatic IGF-1-messenger RNA expression in postoperative parenterally fed rats.
Inaba T; Saito H; Fukushima R; Hashiguchi Y; Lin MT; Inoue T; Fukatsu K; Muto T; Takenaka A; Takahashi S; Noguchi T
JPEN J Parenter Enteral Nutr; 1996; 20(5):325-31. PubMed ID: 8887900
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor 1 has beneficial effects, whereas growth hormone has limited effects on postoperative protein metabolism, gut integrity, and splenic weight in rats with chronic mild liver injury.
Inaba T; Saito H; Fukushima R; Hashiguchi Y; Lin MT; Inoue T; Fukatsu K; Muto T; Oka T; Takenaka A; Takahashi S; Noguchi T
JPEN J Parenter Enteral Nutr; 1997; 21(2):55-62. PubMed ID: 9084006
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
[TBL] [Abstract][Full Text] [Related]
4. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
Grøfte T; Wolthers T; Jensen SA; Møller N; Jørgensen JO; Tygstrup N; Orskov H; Vilstrup H
Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of intestinal growth is associated with increased insulin-like growth factor-binding protein 5 mRNA in the jejunal mucosa of insulin-like growth factor-I-treated parenterally fed rats.
Yang H; Ney DM; Peterson CA; Lo HC; Carey HV; Adamo ML
Proc Soc Exp Biol Med; 1997 Dec; 216(3):438-45. PubMed ID: 9402151
[TBL] [Abstract][Full Text] [Related]
6. Effects of insulin-like growth factor-I and growth hormone in models of parenteral nutrition.
Ney DM
JPEN J Parenter Enteral Nutr; 1999; 23(6 Suppl):S184-9. PubMed ID: 10571453
[TBL] [Abstract][Full Text] [Related]
7. GH elevates serum IGF-I levels but does not alter mucosal atrophy in parenterally fed rats.
Peterson CA; Carey HV; Hinton PL; Lo HC; Ney DM
Am J Physiol; 1997 May; 272(5 Pt 1):G1100-8. PubMed ID: 9176219
[TBL] [Abstract][Full Text] [Related]
8. Enterotrophic effect of insulin-like growth factor-I but not growth hormone and localized expression of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and -5 mRNAs in jejunum of parenterally fed rats.
Peterson CA; Gillingham MB; Mohapatra NK; Dahly EM; Adamo ML; Carey HV; Lund PK; Ney DM
JPEN J Parenter Enteral Nutr; 2000; 24(5):288-95. PubMed ID: 11011784
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats.
Domené H; Krishnamurthi K; Eshet R; Gilad I; Laron Z; Koch I; Stannard B; Cassorla F; Roberts CT; LeRoith D
Endocrinology; 1993 Aug; 133(2):675-82. PubMed ID: 7688291
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and insulin-like growth factor-I counteracts established steroid catabolism in rats by effects on hepatic amino-N degradation.
Grøfte T; Jensen DS; Greisen J; Tygstrup N; Vilstrup H
J Hepatol; 2001 Dec; 35(6):700-6. PubMed ID: 11738095
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous treatment with IGF-I and GH additively increases anabolism in parenterally fed rats.
Lo HC; Hinton PS; Peterson CA; Ney DM
Am J Physiol; 1995 Aug; 269(2 Pt 1):E368-76. PubMed ID: 7653554
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity to exogenous GH and reversibility of the reduced IGF-I gene expression in aging rats.
Velasco B; Cacicedo L; Melian E; Fernández-Vázquez G; Sánchez-Franco F
Eur J Endocrinol; 2001 Jul; 145(1):73-85. PubMed ID: 11415855
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I prevents gut atrophy and maintains intestinal integrity in septic rats.
Chen K; Okuma T; Okamura K; Tabira Y; Kaneko H; Miyauchi Y
JPEN J Parenter Enteral Nutr; 1995; 19(2):119-24. PubMed ID: 7609275
[TBL] [Abstract][Full Text] [Related]
14. The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats.
Gu Y; Wu ZH
World J Gastroenterol; 2002 Aug; 8(4):752-7. PubMed ID: 12174391
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone or insulin-like growth factor I increases fat oxidation and decreases protein oxidation without altering energy expenditure in parenterally fed rats.
Lo HC; Hirvonen MD; Kritsch KR; Keesey RE; Ney DM
Am J Clin Nutr; 1997 May; 65(5):1384-90. PubMed ID: 9129466
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I, but not growth hormone, is dependent on a high protein intake to increase nitrogen balance in the rat.
Sánchez-Gómez M; Malmlöf K; Mejía W; Bermudez A; Ochoa MT; Carrasco-Rodríguez S; Skottner A
Br J Nutr; 1999 Feb; 81(2):145-52. PubMed ID: 10450333
[TBL] [Abstract][Full Text] [Related]
17. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
Melián E; Velasco B; Barrios R; Sanchez-Franco F
Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
[TBL] [Abstract][Full Text] [Related]
18. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
Böni-Schnetzler M; Hauri C; Zapf J
Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery.
Bjarnason R; Wickelgren R; Hermansson M; Hammarqvist F; Carlsson B; Carlsson LM
J Clin Endocrinol Metab; 1998 May; 83(5):1566-72. PubMed ID: 9589657
[TBL] [Abstract][Full Text] [Related]
20. Altered chicken thyroid hormone metabolism with chronic GH enhancement in vivo: consequences for skeletal muscle growth.
Vasilatos-Younken R; Zhou Y; Wang X; McMurtry JP; Rosebrough RW; Decuypere E; Buys N; Darras VM; Van Der Geyten S; Tomas F
J Endocrinol; 2000 Sep; 166(3):609-20. PubMed ID: 10974655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
